Literature DB >> 7023318

Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.

K M Brinkhous, M S Read, R L Reddick, T R Griggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7023318     DOI： 10.1111/j.1749-6632.1981.tb29732.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.

Authors:  K M Brinkhous; U Hedner; J B Garris; V Diness; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 2.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].

Authors:  H R Gralnick; S Williams; L McKeown; W Kramer; H Krutzsch; M Gorecki; A Pinet; L I Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

Authors:  K M Brinkhous; H Sandberg; J B Garris; C Mattsson; M Palm; T Griggs; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.

Authors:  R Manjunatha Kini
Journal:  Toxicon X       Date:  2020-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.